BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ram Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI at the National Institutes of Health’s (NIH) National Heart, Lung and Blood Institute (NHLBI). Dr. Aiyar will help advance fundamental research discoveries to new therapeutics, diagnostics and devices that can be used clinically and commercially.
“We’re pleased to add Dr. Aiyar to our roster of Entrepreneurs-in-Residence,” said Rich Bendis, BHI President and CEO. “He is now our third EIR – joining Todd Chappell, who is EIR at NIH, and Ken Malone, our EIR working with the University of Maryland Ventures. The growth of this program will be a benefit to BHI and our partner organizations for years to come, and will result in transitioning more early-stage biomedical technologies to commercial potential. ”
POSITION DESCRIPTION – Health IT Entrepreneur-in-Residence The Health IT Entrepreneur-in-Residence (EIR) will lead in the evaluation of early-stage health IT technologies, advise BHI on opportunities for new ventures, and build a portfolio commercially relevant health IT opportunities. The Health IT EIR influences the BHI organization by managing and providing information, intelligence and insights that drive critical business decisions. The Health IT EIR will work with early stage companies to launch and validate those companies while providing recommendations and insights on the direction of potential technologies. The Health IT EIR has the potential to also serve in a co-management role in a health IT accelerator.
The award luncheon will provide countless opportunities to show your appreciation for the estimated 33,000 small businesses of Montgomery County—businesses that contribute directly to the strength of the area’s economy. Eight awards will be presented to eight distinct companies.
Registration and networking with exhibits will begin at 11:00 AM, followed by the program at 12:00 PM./p>
America urgently needs a national, research-based effort to empower all undergraduates and help more of them, particularly underrepresented minorities, graduate with science and engineering degrees, said Freeman Hrabowski, III, president of the University of Maryland, Baltimore County (UMBC) during the 2013 William D. Carey lecture.
Hrabowski addressed the 38th Annual AAAS Forum on Science and Technology Policy on 2 May 2013—fifty years to the day after he had participated in the historic Birmingham Children’s March, which was inspired by the late Dr. Martin Luther King, Jr. “I wanted a better education,” Hrabowski said of his participation in that 1963 event. “All children really do want to be well-educated.”
The Economic Alliance of Greater Baltimore and the Maryland Department of Business of Economic Development announced Monday that they created a new program to help companies that have moved beyond the start-up phase to continue to grow.
Advance Maryland is designed to assist these companies with developing markets, fine-tuning their business models and boosting growth with the help of a research specialist. Similar models have been adopted in other states, the groups said.
Please join us for an exclusive MedTech networking event hosted by QIAGEN. Learn more about AdvaMed 2013: The MedTech Conference and discover your local MedTech community.
The Tech Council of Maryland (TCM), the state’s largest technology trade association with more than 400 biotechnology and technology members employing more than 200,000 in the region, announced at its 25th annual Dinner and Awards Celebration last night that Doug Doerfler was elected as chairman of TCM’s board. Doerfler was the association’s vice chairman and succeeds Larry Letow, who has served as chairman since 2010. TCM also named four current board members to executive leadership positions.
“I am honored to continue serving TCM at such an important and promising time,” said Doerfler. “Our members have become the catalysts of Maryland’s dynamic economy, creating new, high-paying jobs and discovering breakthrough technologies that can change our world. We may come from diverse backgrounds, but a single mission unifies us: creating a healthier, safer world with game-changing innovations right here in Maryland. I especially thank Larry Letow for his outstanding board leadership these past three years. He has positioned TCM, our membership and Maryland for a very bright future.”
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association with more than 400 biotechnology and technology members employing more than 200,000 in the region, last night announced the winners of its 2013 TCM Awards. The 25th annual celebration was attended by more than 750 technology and business leaders from around the state.
“Maryland is ripe with innovative companies – from ones focused on high tech and IT solutions that make businesses and governments run smoothly and securely, to biotech companies that are developing cutting-edge cures for serious diseases,” said Doug Doerfler, chairman of TCM’s Board and founding president and CEO of MaxCyte, Inc. “Winners of the 2013 Tech Awards exemplify this broad cross section of individuals and companies that make up the Tech Council membership and are key to driving advances in all aspects of technology.”
As a follow up to a $1 billion initiative last year that funded projects across the nation designed to improve outcomes and save money in the healthcare system, the Centers for Medicaid & Medicare Services today announced a second, $1 billion round of Health Care Innovation Awards.
According to CMS, funding will be awarded to provider groups, health systems, payers, states, public-private partnerships, for-profit organizations or any other parties that have developed innovative payment and delivery models to improve population health, quality of care and cost efficiency.
Fifty years ago this month, I chanced to hear the Rev. Martin Luther King Jr. I was a mild-mannered kid with a speech impediment and a love of math. That day, I was focused on solving math problems, not issues of justice and equal rights. But King broke through to me when he said this: If the children of Birmingham march, Americans will see that what they are asking for is a better education. They will see that even the very young know the difference between right and wrong.
I chose to march, and found myself among hundreds of children jailed for five terrifying days. Mind you, I was not a brave child. But even at 12 years old, I believed and hoped that my participation could make a difference.
A District advisory committee OK’d bids from Johns Hopkins Medicine and MedStar Health to build costly proton therapy centers on Thursday, leaving both just one step from final approval to proceed on the high-tech cancer treatment programs.
It wasn’t, however, a clean victory for either. The committee rejected a key part of Hopkins’ plan and asked for additional details about both nonprofit system’s outreach to under-served neighborhoods.
Having recently stressed that oncology is a core therapy area for its research, AstraZeneca is moving three of its cancer compounds into Phase III trials.
First up, MedImmune, AstraZeneca’s biologics R&D arm, has enrolled the first patient in a late-stage study of moxetumomab pasudotox. It is sponsored by the Cancer Therapy Evaluation Program at the US National Cancer Institute (NCI), and will evaluate the CD22 immunotoxin as a potential treatment in adults with hairy cell leukaemia who have not responded to or relapsed after standard therapy.
Entrepreneur Magazine has named Maryland the No. 1 state to start a new business, with neighboring Virginia following close behind at No. 3.
The California-based magazine cited the state’s Maryland Entrepreneurs Resource List — which connects experts with startups — and the University of Maryland Baltimore County’s initiative to find and train female entrepreneurs in choosing the state for the top position.
Last week, the Baltimore BioPark played host to the Innovation Working Group, which consists of executives from the U.S.-Russia Bilateral Presidential Commission. The commission was founded as a joint venture between President Barack Obama and Russian President Dmitry Medvedev.
The highly anticipated event is an opportunity for the United States and Russia to find new ways to collaborate on projects in the fields of biotech and science. Members of the group were given a tour of the University of Maryland, College Park and Baltimore BioPark. The event was led by Oleg Fomichev, the Russian Deputy Minister of Economy, and Lorraine Hariton, Special Representative for Business and Commerce of the U.S. Department of State. Among those that joined the three day tour were chief executives of biotech companies from both Maryland and Russia, as well as leaders from the Pushchino BioTech Cluster.
Telehealth holds enormous potential for transforming healthcare, but, to telemedicine pioneer Dr. Jay Sanders, the primary barrier is not financial. Instead, physician and patient attitudes about healthcare and health itself must change, said Sanders, who often has been called the father of telemedicine.
“The critical issue is really not telemedicine,” Sanders said in an interview with MobiHealthNews, noting that the term can include telehealth, mobile health, digital health and other forms of e-health. “What’s important is the needs of the healthcare delivery system.”
Would you like to highlight your city and your university research park by hosting AURP’s 2015 International Conference? As the host park, you’ll be recognized as a leader in the field and attract worldwide attention to the exciting progress and success of your region. Find out more about the requirements at AURP.net/hostrfp.
To be considered, submit your proposal, electronically, to VickiePalmer@AURP.net.
Chevy Chase-based New Enterprise Associates stands to reap a fortune from Tableau Software Inc.’s newly public stock, which is up about 60 percent in its first day of trading on the New York Stock Exchange Friday.
NEA is the single biggest venture backer of the Seattle-based data analytics company (NYSE: DATA). The firm sold 1 million shares of Tableau stock in the offering, and is holding on to another 18.5 million shares, or about 37 percent of the company. With Friday’s pop, that stake is valued at more than $900 million.
“Transformation” is the best description of what is happening in health care right now. We are seeing historic changes in how health care is administered in the United States—with increased focus on quality of care versus just paying for a service. We are seeing changes in how people can enroll in health insurance—with the upcoming establishment of a new market place that will help more people get insured in this country than ever before. And, we are seeing changes in how people understand and make decisions about their own health—with an increasing number of tools and services becoming available to help individuals access health information and manage their own personal health data.
BioHealth Innovation (BHI) is a regionally-oriented, private-public partnership functioning as an innovation intermediary focused on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Maryland.
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
POSITION DESCRIPTION – Health IT Entrepreneur-in-Residence
The award luncheon will provide countless opportunities to show your appreciation for the estimated 33,000 small businesses of Montgomery County—businesses that contribute directly to the strength of the area’s economy. Eight awards will be presented to eight distinct companies.
Please join us for an exclusive MedTech networking event hosted by QIAGEN. Learn more about AdvaMed 2013: The MedTech Conference and discover your local MedTech community.
